Prairie Wealth Advisors Inc. Has $380,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Prairie Wealth Advisors Inc. lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 37.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,223 shares of the exchange traded fund’s stock after selling 2,550 shares during the period. Prairie Wealth Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $380,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XBI. Avior Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC raised its stake in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at $40,000. ORG Wealth Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at $44,000. Finally, Howe & Rusling Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $49,000.

SPDR S&P Biotech ETF Stock Down 1.4 %

Shares of SPDR S&P Biotech ETF stock opened at $93.37 on Friday. The stock has a market capitalization of $7.12 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The company has a 50-day simple moving average of $92.75 and a 200 day simple moving average of $96.55.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.